Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Heterogeneity in major depressive disorder: The need for biomarker-based personalized treatments
Shayam Suseelan, Graziano Pinna
Advances in clinical chemistry (2022), pp. 1-67
Closed Access | Times Cited: 15

Showing 15 citing articles:

Ononin ameliorates depression-like behaviors by regulating BDNF-TrkB-CREB signaling in vitro and in vivo
Guowei Gong, Kumar Ganesan, Yongjie Wang, et al.
Journal of Ethnopharmacology (2023) Vol. 320, pp. 117375-117375
Closed Access | Times Cited: 15
Clinical pharmacological innovation in the treatment of depression
Jeffrey M. Witkin, Lalit K. Golani, Jodi L. Smith
Expert Review of Clinical Pharmacology (2023) Vol. 16, Iss. 4, pp. 349-362
Closed Access | Times Cited: 14
Emerging roles of epigenetics in lead-induced neurotoxicity
Zongqin Mei, Guofen Liu, Bo Zhao, et al.
Environment International (2023) Vol. 181, pp. 108253-108253
Open Access | Times Cited: 14
Zhi‐zi‐chi decoction mitigates depression by enhancing lncRNA Six3os1 expression and promoting histone H3K4 methylation at the BDNF promoter
Tianyu Zou, Kazuo Sugimoto, Yu Zhao, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 11
Open Access | Times Cited: 4
Metabolomics signatures of serotonin reuptake inhibitor (escitalopram), serotonin norepinephrine reuptake inhibitor (duloxetine) and cognitive-behavioral therapy on key neurotransmitter pathways in major depressive disorder
Sudeepa Bhattacharyya, Siamak MahmoudianDehkordi, Matthew J. Sniatynski, et al.
Journal of Affective Disorders (2025)
Open Access
Association of inflammation cytokines with cognitive function in first-episode major depressive disorder
Xi Yali, Z Wang, G. Li, et al.
Frontiers in Psychiatry (2025) Vol. 15
Open Access
Identification and experimental validation of biomarkers associated with mitochondrial and programmed cell death in major depressive disorder
Shijiao Xiong, Lin Liao, Meng Chen, et al.
Frontiers in Psychiatry (2025) Vol. 16
Open Access
Metabolic rewiring and autophagy inhibition correct lysosomal storage disease in mucopolysaccharidosis IIIB
Melania Scarcella, Gianluca Scerra, Mariangela Ciampa, et al.
iScience (2024) Vol. 27, Iss. 3, pp. 108959-108959
Open Access | Times Cited: 3
Current Strategies and Future Directions of Wearable Biosensors for Measuring Stress Biochemical Markers for Neuropsychiatric Applications
Zach Sheffield, Priyanka Paul, Shraddha Krishnakumar, et al.
Advanced Science (2024)
Closed Access | Times Cited: 1
Biomarkers and treatments for mood disorders encompassing the neurosteroid and endocannabinoid systems
Graziano Pinna
Journal of Neuroendocrinology (2022) Vol. 35, Iss. 2
Closed Access | Times Cited: 6
GRP94 in cerebrospinal fluid may contribute to a potential biomarker of depression: Based on proteomics
Kaige Liu, Yue Qu, Bozhi Li, et al.
Journal of Psychiatric Research (2023) Vol. 169, pp. 328-340
Closed Access | Times Cited: 2
Reduced urine pregnenolone concentration after clinical response in patients with depression: An open-label short-term prospective study
Bruno Pedraz‐Petrozzi, Eva Kathrin Lamadé, Rebekka Schneiberg, et al.
Psychoneuroendocrinology (2023) Vol. 157, pp. 106366-106366
Closed Access | Times Cited: 1
Associations of prenatal maternal depressive symptoms with cord blood glucocorticoids and child hair cortisol levels in the project viva and the generation R cohorts: a prospective cohort study
Nathan Cohen, Serena Defina, Sheryl L. Rifas‐Shiman, et al.
BMC Pediatrics (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Heterogeneous Graph Attention Networks for Depression Identification by Campus Cyber-Activity Patterns
Minqiang Yang, Zhuoheng Li, Yujie Gao, et al.
IEEE Transactions on Computational Social Systems (2024) Vol. 11, Iss. 3, pp. 3493-3503
Closed Access
Metabolomics Signatures of serotonin reuptake inhibitor (Escitalopram), serotonin norepinephrine reuptake inhibitor (Duloxetine) and Cognitive Behavioral Therapy on Key Neurotransmitter Pathways in Major Depressive Disorder
Sudeepa Bhattacharyya, Siamak MahmoudianDehkordi, Matthew J. Sniatynski, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Page 1

Scroll to top